Dr. Peiliang Wang is a Specially-appointed Associate Professor and Master's Supervisor at the Institute of Cell and Gene Technology, Shenzhen University of Advanced Technology. He is experienced in interdisciplinary collaboration with clinicians across medical specialties and with teams in biomedical engineering and bioinformatics. His research focuses on developing and optimizing technology platforms for the directed differentiation of human pluripotent stem cells (hPSCs) into hematopoietic and immune cells for industrial application, investigating the developmental mechanisms of the resulting hematopoietic and immune cells, and advancing the clinical translation of hPSC-derived blood and immune cells. In parallel, he uses hPSC-derived endothelial cells to explore therapeutic applications for ischemic diseases and develops hPSC-derived vascularized organoids containing tissue-resident immune cells for disease modeling and drug screening. He received the 2025 International Society for Stem Cell Research (ISSCR) Travel Award, the 2025 Outstanding Postdoctoral Fellowship from the Peking University–Tsinghua Center for Life Sciences, and Tsinghua University Comprehensive Excellence Scholarships in 2020 and 2022. He serves as principal investigator on one Youth Program project funded by the Beijing Natural Science Foundation. In recent years, he has published 15 papers as first author, corresponding author, or co-author in journals including Biomaterials, Advanced Science, and Nature Communications, and has four invention patents that have either been granted or are under examination.

2010.08–2014.07    Bachelor's Degree    School of Life Sciences, Northwestern Polytechnical University

2014.08–2017.07    Master's Degree    School of Life Sciences, Sun Yat-sen University

2019.08–2024.07    Ph.D.    School of Basic Medical Sciences, Tsinghua University

2017.07–2018.03    Technician    Livzon Pharmaceutical Group Inc.

2024.07–2026.09    Postdoctoral Fellow / Assistant Researcher    School of Basic Medical Sciences, Tsinghua University

2026.09–Present    Specially-appointed Associate Professor    Institute of Cell and Gene Technology, Shenzhen University of Advanced Technology

Stem Cells and Regenerative Medicine; Cell Therapy; Organoids

2025–2027    Beijing Natural Science Foundation Youth Program    Principal Investigator    RMB 200,000

2026–2028    National Key Laboratory of Membrane Biology–Beijing Tsinghua Changgung Hospital Joint Fund    Participant    RMB 300,000

1.Peiliang Wang^#,Hui Qiu^#, Xia Chen^#, et al. Porous microscaffold enables spontaneous hematopoietic cell differentiation and continuous macrophage production from hPSCs for therapy. Biomaterials, 2026, 326. 123638. IF12.9

2.Mengda Li^#, Peiliang Wang^#, Hui Qiu^#, et al. hPSC derived endothelial cells repair Choroidal ischemia. Advanced science, 2023,08,2198-3844，2302940. IF15.1

3.Xia Chen^#, Peiliang Wang^#, Hui Qiu^#, et al. Integrative epigenomic and transcriptomic analysis reveals the requirement of JUNB for hematopoietic fate induction. Nature Communications, 2022, 13(1) 3131. IF16.6

4. Yonglin Zhu, Jinyang Liu, Jia Wang, Shuangyuan Ding, Hui Qiu, Xia Chen, Jianying Guo, Peiliang Wang, et al. Integrative transcriptomic and epigenomic analysis identifies BCL6B as a novel regulator of human pluripotent stem cell to endothelial differentiation. Protein&Cell, 2025. IF12.9

5. Yaxuan Zhang^#, Xingwu Zhang^#, Fuyu Duan^#, Huimin Qiao^#, Mingli Gong^#, Hui Qiu, Xia Chen, Peiliang Wang, et al. Modeling antiviral response in the liver using human pluripotent stem cell-derived macrophages, Life Medicine,3 (1),2024, lnae001. IF 7.7

6. Tongyue Chen^#, Lirong Guo^#, Han Zhang, Bing Cai, Yong Gao, Peiliang Wang, et al. An evolutionarily young gene TTRP is recruited in human circadian clock. 2026, Nature Communications. NCOMMS-25-68615B. Accepted.IF16.6

7. Silin Li^#, Zengxuan Zhou^#, Yufeng Wan^#, Xudong Jia, Peiliang Wang, et al. Reconstruction of the ancient cyanobacterial proto-circadian clock system KaiABC. EMBO JOURNAL. 2025 May;44(10):3025-3046. IF11.4

8.Xianyun Chen, Xiaolan Liu, Xihui Gan, Silin Li, Huan Ma, Lin Zhang, Peiliang Wang, et al. Differential regulation of phosphorylation, structure, and stability of circadian clock protein FRQ isoforms. J Biol Chem,2023, 299(4) 104597. IF 5.486

1. Jie Na, Peiliang Wang, Xia Chen, Yaxuan Zhang. Reagent for preparing macrophages by differentiation of human pluripotent stem cells and use thereof. 2022. (Invention patent, granted; Patent No.: ZL 202210808475.8)